Maternova is a woman-owned, woman-run social enterprise based in Providence, Rhode Island that curates, evaluates, and distributes evidence-based medical devices and diagnostics for maternal, neonatal, and reproductive health in low- and middle-income countries. Founded in 2009 as the first e-commerce marketplace for global health technologies, it connects inventors and manufacturers who lack distribution with the governments, NGOs, hospitals, and clinicians who need life-saving tools - aggregating small orders to unlock manufacturing runs and accelerate access to innovations that prevent maternal and infant deaths.
Noveome Biotherapeutics is a Pittsburgh clinical-stage biopharmaceutical company built around ST266, a multi-targeted secretome of hundreds of biologically active proteins harvested from a novel population of amnion-derived cells. Rather than transplanting cells, Noveome delivers the healing signals those cells secrete - aiming to modulate inflammation, protect nerves, and accelerate tissue repair. Its lead program treats necrotizing enterocolitis, a devastating gut disease in premature infants, with additional pipeline work spanning ophthalmology, neurology, and dermatology.
Dr. M. Gabriela Salvador is the CEO of Maternova, Inc., a Providence-based global health company that runs an e-commerce marketplace for vetted, life-saving medical devices, diagnostics and nutrition products aimed at low- and middle-income countries. A physician trained as a pediatric ophthalmologist in Argentina, the United States and Mexico, she spent two decades building high-impact health programs at Americares, Grameen Foundation, Freedom from Hunger and Pro Mujer before taking the helm at Maternova in March 2023. Originally from Salta, Argentina, she pairs a medical degree from the National University of Cordoba with a Harvard MPH in health policy and management.